Hiv replication inhibiting purine derivatives
    9.
    发明申请
    Hiv replication inhibiting purine derivatives 有权
    Hiv复制抑制嘌呤衍生物

    公开(公告)号:US20060293330A1

    公开(公告)日:2006-12-28

    申请号:US10573364

    申请日:2004-09-21

    摘要: The present invention relates to the use of a compound of formula (I) for the manufacture of a medicament for the prevention or the treatment of HIV infection wherein the compound of formula (I) is a compound of formula a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine or a stereochemically isomeric form thereof, wherein A and B each represents a radical of formula and wherein —C-D- represents a bivalent radical of formula —N═CH—NR17—  (c-1); or —NR7—CH═N—  (c-2); provided that when A represents a radical of formula (a) then B represents a radical of formula (b) and when A represents a radical of formula (b) then B represents a radical of formula (a).

    摘要翻译: 本发明涉及式(I)化合物在制备用于预防或治疗HIV感染的药物中的用途,其中式(I)化合物为式I化合物,N-氧化物,药学上 其中A和B各自表示下式的基团,其中-CD-表示式<β的二价基团。在线式描述=“在线式” - 末端=“铅”→N-CH-NR 17 - (c-1); 或<?in-line-formula description =“In-line Formulas”end =“tail”?> <?in-line-formula description =“In-line Formulas”end =“lead”?> - NR < 7 -CH-N-(c-2); 条件是当A表示式(a)的基团时,B表示式(b)的基团,并且当A表示基团时,<?in-line-formula description =“In-line Formulas”end =“tail” 式(b)所示的B为式(a)的基团。